Inogen Inc

INGN.US
Healthcare · Medical Devices
6.42
+0.11 (+1.74%)
USD · NASDAQ

Company Information

Company Name
Inogen Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US45780L1044
CIK: 0001294133
CUSIP: 45780L104
Currency: USD
Full Time Employees: 753
Phone: 805 562 0500
Fiscal Year End: December
IPO Date: Feb 14, 2014
Description:

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

Address:

500 Cummings Center, Beverly, MA, United States, 01915

People

Directors & Officers

Name Title Year Born
Mr. Kevin R. M. Smith President, CEO & Director 1971
Mr. Kevin P. Smith General Counsel, Secretary & Executive VP of Business Development 1971
Ms. Jennifer Yi Boyer Executive VP of Enterprise Enablement & Chief Human Resources Officer 1975

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
May 10, 2024 Jason Somer N/A Sale 10.00K $8.56 $85.60K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 1.65M Mar 31, 2026 6.08% $0.00 -4.06%
Vanguard Group Inc 1.42M Dec 31, 2025 5.25% $0.00 -0.63%
Armistice Capital, LLC 1.20M Mar 31, 2026 4.43% $0.13 -5.06%
Acadian Asset Management LLC 1.08M Mar 31, 2026 4.00% $0.01 5,444.10%
Vanguard Capital Management, LLC 1.04M Mar 31, 2026 3.83% $0.00 0.00%
Ameriprise Financial Inc 859.54K Mar 31, 2026 3.17% $0.00 -0.12%
Dafna Capital Management LLC 845.18K Mar 31, 2026 3.12% $1.19 2.19%
Point72 Asset Management, L.P. 642.37K Mar 31, 2026 2.37% $0.01 218.08%
Geode Capital Management, LLC 613.53K Mar 31, 2026 2.27% $0.00 2.36%
Arrowstreet Capital Limited Partnership 586.16K Mar 31, 2026 2.17% $0.00 203.95%
The Goldman Sachs Group Inc 580.10K Mar 31, 2026 2.14% $0.00 -1.56%
State Street Corp 573.20K Mar 31, 2026 2.12% $0.00 12.00%
Morgan Stanley - Brokerage Accounts 541.17K Mar 31, 2026 2.00% $0.00 -3.08%
Federated Hermes Inc 514.66K Mar 31, 2026 1.90% $0.01 6.03%
Dimensional Fund Advisors, Inc. 509.82K Mar 31, 2026 1.88% $0.00 -28.33%
Renaissance Technologies Corp 478.80K Mar 31, 2026 1.77% $0.00 -17.87%
JPMorgan Chase & Co 427.66K Mar 31, 2026 1.58% $0.00 -8.87%
AQR Capital Management LLC 427.12K Mar 31, 2026 1.58% $0.00 90.15%
CSM Advisors, LLC 413.88K Mar 31, 2026 1.53% $0.06 -0.51%
Prudential Financial Inc 369.07K Mar 31, 2026 1.36% $0.00 -19.43%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 739.97K 2.73% ▲ 0.00% Jun 30, 2026
2 CS McKee Micro Cap Value 662.45K 2.45% ▲ 0.00% Jun 30, 2026
3 iShares Russell 2000 ETF 647.60K 2.39% ▲ 0.60% Jun 30, 2026
4 Columbia Small Cap Value Discv A 623.31K 2.30% ▲ 0.74% Jun 30, 2026
5 Columbia Small Cap Value Discovery Fund 623.31K 2.30% ▲ 3.01% Jun 30, 2026
6 Federated Hermes MDT Small Cap Core IS 371.38K 1.37% ▲ 0.00% Mar 31, 2026
7 Federated Hermes MDT SCC Institutional 371.38K 1.37% ▲ 0.00% Mar 31, 2026
8 Vanguard Institutional Extnd Mkt Idx Tr 271.20K 1.00% ▲ 0.00% Jun 30, 2026
9 Fidelity Small Cap Index 234.30K 0.87% ▲ 1.17% Apr 30, 2026
10 iShares Russell 2000 Value ETF 217.75K 0.80% ▼ 0.69% Jun 30, 2026

Financial Highlights

Market Cap: $173.82M
EBITDA: $-8.81M
PEG Ratio: $3.48
Book Value: $6.68
Earnings/Share: $-0.93
Profit Margin: -7.08%
Operating Margin: -9.89%
ROA (TTM): -6.14%
ROE (TTM): -13.07%
Revenue (TTM): $351.50M
Revenue/Share (TTM): $12.95
Earnings Growth (YOY): 87.30%
Revenue Growth (YOY): 3.40%

Valuation Metrics

Enterprise Value: $77.60M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 27.07M
Shares Float: 23.68M
% Insiders: 1,263.70%
% Institutions: 7,679.60%
Short % Float: 3.96%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$348.67M
Cost of Goods Sold
adjust
$-182.78M
Gross Profit
subtotal
$165.89M
SG&A
adjust
$-67.38M
R&D
adjust
$-19.40M
Other Operating Expense
adjust
$-109.32M
Operating Income
subtotal
$-30.21M
Other / Non-Operating Items
adjust
$7.46M
Net Income
subtotal
$-22.75M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about INGN.US!